TELA Bio (NASDAQ: TELA)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.560 | -0.750 | -0.1900 | ||||
REV | 7.950M | 8.231M | 281.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TELA Bio (NASDAQ: TELA) through any online brokerage.
Other companies in TELA Bio’s space includes: Pulmonx (NASDAQ:LUNG), RxSight (NASDAQ:RXST), Chembio Diagnostics (NASDAQ:CEMI), Predictive Oncology (NASDAQ:POAI) and Meihua International (NASDAQ:MHUA).
The latest price target for TELA Bio (NASDAQ: TELA) was reported by Piper Sandler on Thursday, August 13, 2020. The analyst firm set a price target for 17.00 expecting TELA to rise to within 12 months (a possible 142.86% upside). 0 analyst firms have reported ratings in the last year.
The stock price for TELA Bio (NASDAQ: TELA) is $7 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for TELA Bio.
TELA Bio’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for TELA Bio.
TELA Bio is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.